Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(0.04) per share. This is a 300 percent decrease over losses of $(0.01) per share from the same period last year. The company reported $1.941 thousand in sales this quarter.
Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(0.04) per share. This is a 300 percent decrease over losses of $(0.01) per share from the same period last year. The company reported $1.941 thousand in sales this quarter.
Comments